Wolff Wiese Magana’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Wolff Wiese Magana’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Hold	55	–	–	﹤0.01%	833
2026 Q1	$1.66K	Hold	55	–	–	﹤0.01%	807
2025 Q4	$1.72K	Hold	55	–	–	﹤0.01%	769
2025 Q3	$1.11K	Hold	55	–	–	﹤0.01%	840
2025 Q2	$922	Hold	55	–	–	﹤0.01%	852
2025 Q1	$846	Hold	55	–	–	﹤0.01%	873
2024 Q4	$1.21K	Hold	55	–	–	﹤0.01%	787
2024 Q3	$992	Hold	55	–	–	﹤0.01%	857
2024 Q2	$894	Hold	55	–	–	﹤0.01%	645
2024 Q1	$777	Hold	55	–	–	﹤0.01%	596
2023 Q4	$575	Hold	55	–	–	﹤0.01%	614
2023 Q3	$561	Hold	55	–	–	﹤0.01%	680
2023 Q2	$415	Hold	55	–	–	﹤0.01%	710
2023 Q1	$487	Hold	55	–	–	﹤0.01%	649
2022 Q4	$502	Hold	55	–	–	﹤0.01%	643
2022 Q3	$0	Hold	55	–	–	﹤0.01%	968
2022 Q2	$0	Hold	55	–	–	﹤0.01%	969
2022 Q1	$1K	Hold	55	–	–	﹤0.01%	787
2021 Q4	$0	Hold	55	–	–	﹤0.01%	856
2021 Q3	$1K	Hold	55	–	–	﹤0.01%	786
2021 Q2	$1K	Hold	55	–	–	﹤0.01%	809
2021 Q1	$1K	Hold	55	–	–	﹤0.01%	717
2020 Q4	$1K	Buy	+55	New	+$527	﹤0.01%	665

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Wolff Wiese Magana's TEVA Position: Q2 2026 in Review

Wolff Wiese Magana held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 55 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Wolff Wiese Magana first reported a position in TEVA in Q4 2020 and has held it in 23 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Wolff Wiese Magana held 55 shares of Teva Pharmaceutical Industries Limited worth $1.86K as of Q2 2026.
Wolff Wiese Magana left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #833 holding.
Wolff Wiese Magana first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and has held it in 23 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.